Showing results (81-90 of 130) with videos related to

Sort By:
Pageof 13
Proceedings of the National Academy of Sciences of the United States of America|April 20, 2026
Failure of early B cell tolerance and possible BCR signaling dysregulation underlie NF155-mediated autoimmune nodopathiesBhaskar Roy, Abeer H Obaid, Zhenjian Wang, et al.
Neurology and Therapy|May 6, 2022
Impact of Neuromyelitis Optica Spectrum Disorder on Quality of Life from the Patients' Perspective: An Observational Cross-Sectional StudyJosé E Meca-Lallana, Rocío Gómez-Ballesteros, Francisco Pérez-Miralles, et al.
Journal of the Peripheral Nervous System : JPNS|February 6, 2026
Effect of Rituximab on Neurofilament Levels in CIDP: Results From the CIDPRIT Randomized TrialPietro Emiliano Doneddu, Roger Collet-Vidiella, Chiara Gallo, et al.
BMC Neurology|October 25, 2024
Inflammatory Neuropathy Consortium base (INCbase): a protocol of a global prospective observational cohort study for the development of a prediction model for treatment response in chronic inflammatory demyelinating polyneuropathyMilou R Michael, Luuk Wieske, Jeffrey A Allen, et al.
Annals of Clinical and Translational Neurology|June 22, 2018
The impact of rituximab infusion protocol on the long-term outcome in anti-MuSK myasthenia gravisElena Cortés-Vicente, Ricard Rojas-Garcia, Jordi Díaz-Manera, et al.
Multiple Sclerosis and Related Disorders|August 31, 2024
Does serum neurofilament light chain measurement influence therapeutic decisions in multiple sclerosis?Gustavo Saposnik, Enric Monreal, Nicolas Medrano, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|June 4, 2026
Prognostic Determinants of Presentation and Outcome in Anti-IgLON5 DiseaseLidia Sabater, Mar Guasp, Raquel Ruiz García, et al.
Plos One|July 29, 2021
Quantifying the patient´s perspective in neuromyelitis optica spectrum disorder: Psychometric properties of the SymptoMScreen questionnaireJosé E Meca-Lallana, Jorge Maurino, Francisco Pérez-Miralles, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|June 21, 2022
Immune Response and Safety of SARS-CoV-2 mRNA-1273 Vaccine in Patients With Myasthenia GravisDavid Reyes-Leiva, Joaquín López-Contreras, Esther Moga, et al.
Journal of Autoimmunity|March 19, 2013
PhIP-Seq characterization of autoantibodies from patients with multiple sclerosis, type 1 diabetes and rheumatoid arthritisH Benjamin Larman, Uri Laserson, Luis Querol, et al.
Pageof 13